<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://medlabwiki.com/index.php?action=history&amp;feed=atom&amp;title=Red_Blood_Cell_Morphology</id>
	<title>Red Blood Cell Morphology - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://medlabwiki.com/index.php?action=history&amp;feed=atom&amp;title=Red_Blood_Cell_Morphology"/>
	<link rel="alternate" type="text/html" href="https://medlabwiki.com/index.php?title=Red_Blood_Cell_Morphology&amp;action=history"/>
	<updated>2026-05-25T22:26:06Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.45.3</generator>
	<entry>
		<id>https://medlabwiki.com/index.php?title=Red_Blood_Cell_Morphology&amp;diff=154&amp;oldid=prev</id>
		<title>Admin: /* Visible by normal staining */</title>
		<link rel="alternate" type="text/html" href="https://medlabwiki.com/index.php?title=Red_Blood_Cell_Morphology&amp;diff=154&amp;oldid=prev"/>
		<updated>2025-02-03T15:21:41Z</updated>

		<summary type="html">&lt;p&gt;&lt;span class=&quot;autocomment&quot;&gt;Visible by normal staining&lt;/span&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 11:21, 3 February 2025&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l256&quot;&gt;Line 256:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 256:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|Howell-Jolly bodies&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|Howell-Jolly bodies&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;DNA&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l262&quot;&gt;Line 262:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 262:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|Pappenheimer bodies&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|Pappenheimer bodies&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Iron&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l268&quot;&gt;Line 268:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 268:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|Basophillic stippling&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|Basophillic stippling&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;RNA&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Admin</name></author>
	</entry>
	<entry>
		<id>https://medlabwiki.com/index.php?title=Red_Blood_Cell_Morphology&amp;diff=153&amp;oldid=prev</id>
		<title>Admin at 18:46, 2 February 2025</title>
		<link rel="alternate" type="text/html" href="https://medlabwiki.com/index.php?title=Red_Blood_Cell_Morphology&amp;diff=153&amp;oldid=prev"/>
		<updated>2025-02-02T18:46:53Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;a href=&quot;https://medlabwiki.com/index.php?title=Red_Blood_Cell_Morphology&amp;amp;diff=153&amp;amp;oldid=138&quot;&gt;Show changes&lt;/a&gt;</summary>
		<author><name>Admin</name></author>
	</entry>
	<entry>
		<id>https://medlabwiki.com/index.php?title=Red_Blood_Cell_Morphology&amp;diff=138&amp;oldid=prev</id>
		<title>Admin: Created page with &quot;{| class=&quot;wikitable&quot; |+ !RBC Trait !Appearance !Physiology !Associated Conditions !Follow-up Testing |- |Rouleaux |Stacked formation (&quot;stack of coins&quot;) in monolayer  * Often seen with blue background staining | * Increased amount of plasma proteins * Excess protein have + charge that reduces RBC membrane charge (zeta potential) * Reduced charge allows cells to stack (due to biconcave shape) | * Multiple myeloma/plasma cell myeloma * Chronic liver disease * Lymphomas * Ac...&quot;</title>
		<link rel="alternate" type="text/html" href="https://medlabwiki.com/index.php?title=Red_Blood_Cell_Morphology&amp;diff=138&amp;oldid=prev"/>
		<updated>2025-01-27T23:25:27Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;{| class=&amp;quot;wikitable&amp;quot; |+ !RBC Trait !Appearance !Physiology !Associated Conditions !Follow-up Testing |- |Rouleaux |Stacked formation (&amp;quot;stack of coins&amp;quot;) in monolayer  * Often seen with blue background staining | * Increased amount of plasma proteins * Excess protein have + charge that reduces RBC membrane charge (zeta potential) * Reduced charge allows cells to stack (due to biconcave shape) | * Multiple myeloma/plasma cell myeloma * Chronic liver disease * Lymphomas * Ac...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+&lt;br /&gt;
!RBC Trait&lt;br /&gt;
!Appearance&lt;br /&gt;
!Physiology&lt;br /&gt;
!Associated Conditions&lt;br /&gt;
!Follow-up Testing&lt;br /&gt;
|-&lt;br /&gt;
|Rouleaux&lt;br /&gt;
|Stacked formation (&amp;quot;stack of coins&amp;quot;) in monolayer&lt;br /&gt;
&lt;br /&gt;
* Often seen with blue background staining&lt;br /&gt;
|&lt;br /&gt;
* Increased amount of plasma proteins&lt;br /&gt;
* Excess protein have + charge that reduces RBC membrane charge (zeta potential)&lt;br /&gt;
* Reduced charge allows cells to stack (due to biconcave shape)&lt;br /&gt;
|&lt;br /&gt;
* Multiple myeloma/plasma cell myeloma&lt;br /&gt;
* Chronic liver disease&lt;br /&gt;
* Lymphomas&lt;br /&gt;
* Acute and chronic inflammatory diseases (especially when plasma proteins like fibrinogen or globulins are increased)&lt;br /&gt;
|Saline replacement to remove excess protein&lt;br /&gt;
|-&lt;br /&gt;
|Agglutination&lt;br /&gt;
|Irregular clumping of cells in monolayer&lt;br /&gt;
|&lt;br /&gt;
* Caused by IgM antibodies (cold agglutinins)&lt;br /&gt;
* Large antibodies can span zeta potential gaps and form lattice with other antibody-coated cells&lt;br /&gt;
* IgMs bind to RBCs at room temperature&lt;br /&gt;
|&lt;br /&gt;
* Cold autoimmune hemolytic anemia&lt;br /&gt;
* IgM-associated lymphomas&lt;br /&gt;
* Multiple myeloma&lt;br /&gt;
* Paroxysmal cold hemoglobinuria&lt;br /&gt;
|Pre-warm sample to 37C to dissociate cold IgMs&lt;br /&gt;
|-&lt;br /&gt;
|Microcytosis&lt;br /&gt;
|Smaller cells (round, biconcave)&lt;br /&gt;
|&lt;br /&gt;
* More divisions causing smaller cells&lt;br /&gt;
* Hemoglobin errors - cells continue dividing to reach adequate hemoglobin concentrations&lt;br /&gt;
|&lt;br /&gt;
* Thalassemia (small, uniform size - N RDW)&lt;br /&gt;
* IDA (small, varying size - ↑ RDW)&lt;br /&gt;
* Anemia of chronic inflammation&lt;br /&gt;
* Lead poisoning&lt;br /&gt;
* Hemoglobinopathies&lt;br /&gt;
* Sideroblastic anemia&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
| rowspan=&amp;quot;2&amp;quot; |Macrocytosis&lt;br /&gt;
|Round macrocytes (size)&lt;br /&gt;
|&lt;br /&gt;
* Increases in cell membrane size (more cholesterol)&lt;br /&gt;
* Retain shape, but with larger membrane&lt;br /&gt;
|Moderate ↑ MCV&lt;br /&gt;
&lt;br /&gt;
* Liver disease&lt;br /&gt;
* Normal neonate&lt;br /&gt;
* Reticulocytosis&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Oval macrocytes (shape)&lt;br /&gt;
|&lt;br /&gt;
* Fewer divisions causing larger cells - errors in DNA synthesis&lt;br /&gt;
* Cytoplasm increases, but DNA doesn&amp;#039;t (asynchrony)&lt;br /&gt;
|Marked ↑ MCV&lt;br /&gt;
&lt;br /&gt;
* Megaloblastic anemia (B12/folate deficiency)&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hypochromasia&lt;br /&gt;
|Cells &amp;gt;1/3 central pallor&lt;br /&gt;
&lt;br /&gt;
* 1/2-2/3 moderate&lt;br /&gt;
* &amp;gt;3/4 marked&lt;br /&gt;
* Consistent field-to-field, gradual colour change&lt;br /&gt;
|&lt;br /&gt;
* Decreased or abnormal hemoglobin&lt;br /&gt;
|&lt;br /&gt;
* IDA&lt;br /&gt;
* Thalassemias&lt;br /&gt;
* Sideroblastic anemia&lt;br /&gt;
* Lead poisoning&lt;br /&gt;
* Some anemia of chronic inflammation&lt;br /&gt;
|↓ MCH, ↓ MCHC&lt;br /&gt;
|-&lt;br /&gt;
|Increased polychromasia&lt;br /&gt;
|Larger, irregular bluish cells, without central pallor&lt;br /&gt;
|&lt;br /&gt;
* Cells at final stage of RBC maturation&lt;br /&gt;
* Have lost nucleus but have not assumed final biconcave shape&lt;br /&gt;
* Increase indicates bone marrow response to push out immature cells (compensatory mechanism)&lt;br /&gt;
|&lt;br /&gt;
* 0.5-2.5% normal in adults&lt;br /&gt;
* Increased in conditions causing RBC damage or destruction&lt;br /&gt;
|Reticulocyte count&lt;br /&gt;
&lt;br /&gt;
* Manual supravital staining (methylene blue to visualize RNA)&lt;br /&gt;
* Automated immature reticulocyte fraction (IRF) to stain nucleic acids&lt;br /&gt;
|-&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|}&lt;br /&gt;
Combinations&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+&lt;br /&gt;
!&lt;br /&gt;
!&lt;br /&gt;
!&lt;br /&gt;
!&lt;br /&gt;
|-&lt;br /&gt;
|Dual Population&lt;br /&gt;
|Usually normal population with abnormal population&lt;br /&gt;
|&lt;br /&gt;
* Condition being treated (newer, healthy population)&lt;br /&gt;
* Condition plus blood transfusion&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Normocytic/normochromic&lt;br /&gt;
|Normal size and colour of RBC&lt;br /&gt;
|&lt;br /&gt;
* Normal patient&lt;br /&gt;
* Anemia from reduced RBC numbers (hemorrhage, burns, etc.)&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hypochromic/microcytic&lt;br /&gt;
|Small cells with large central pallor&lt;br /&gt;
|&lt;br /&gt;
* Anemia from abnormal hemoglobin production or metabolism (e.g., IDA)&lt;br /&gt;
|&lt;br /&gt;
|}&lt;br /&gt;
RBC Metabolism&lt;br /&gt;
&lt;br /&gt;
RBC Breakdown&lt;br /&gt;
&lt;br /&gt;
Extravascular Hemolysis (Macrophage-Mediated Hemolysis)&lt;br /&gt;
&lt;br /&gt;
* Occurs in spleen, primarily due to splenic macrophages&lt;br /&gt;
* Slower movement through splenic sinusoids allows older or damaged cells to be destroyed&lt;br /&gt;
* RBC contents salvaged and metabolized&lt;br /&gt;
** Hemoglobin broken down into globin chains and iron&lt;br /&gt;
**&lt;br /&gt;
* Most (90%) of RBCs are destroyed this way&lt;br /&gt;
&lt;br /&gt;
Intravascular Hemolysis (Fragmentation/Mechanical Hemolysis)&lt;br /&gt;
&lt;br /&gt;
* Occurs inside blood vessels&lt;br /&gt;
* Mechanical damage to cells causing hemolysis&lt;br /&gt;
** Can also be caused by damage to blood vessels (e.g., clots)&lt;br /&gt;
* RBC contents also salvaged&lt;br /&gt;
** Hemoglobin binds to transport proteins (primarily haptoglobin when available, if hemoglobin oxidizes then binds to hemopexin)&lt;br /&gt;
** Taken to liver (hemoglobin) or excreted by kidney&lt;br /&gt;
* Less common (10-20%) method of RBC destruction&lt;/div&gt;</summary>
		<author><name>Admin</name></author>
	</entry>
</feed>